Fat dissolving injections are generally suitable for adults with localised areas of stubborn fat who are close to their target weight
Common symptoms for both men and women include difficulty losing weight despite proper diet and exercise, increased fat, especially around the abdomen, persistent fatigue, low energy levels, mood swings, low libido, cognitive changes, hot flashes, and sleep disturbances
For injectable GLP-1 medications: Timing requirements : For once-weekly injections (semaglutide [Ozempic, Wegovy], dulaglutide [Trulicity], exenatide extended-release), administration can occur at any time of day, with or without food
The American Diabetes Association and American College of Obstetricians and Gynecologists provide broader guidance on preconception care that applies to GLP-1 receptor agonist use
Store opened pens in a cool, dry place away from direct sunlight, heat sources, and areas with high humidity such as bathrooms